Skip to main navigation Skip to search Skip to main content

PROGRESS in Blood Pressure Control for the Prevention of Secondary Stroke

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

The Perindopril Protection against Recurrent Stroke Study (PROGRESS) grew out of discussions at a World Health Organization/International Society of Hypertension (WHO-ISH) meeting on Hypertension and Cerebrovascular disease held in Nara, Japan, in May 1993 [1].At the time, there was broad consensus that the benefits of blood pressure (BP) lowering were established for the primary prevention of stroke [2], but there was a clear need for further randomised trials to determine the role and possible benefits of BP lowering for the secondary prevention of stroke in patients who had survived a previous stroke as this remained an open question.
Original languageEnglish
Pages (from-to)617-621
Number of pages5
JournalCerebrovascular Diseases
Volume50
Issue number6
DOIs
Publication statusPublished - Dec 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Secondary stroke prevention
  • ·Blood pressure lowering
  • Perindopril and indapamide
  • Asian and Caucasian participants

Fingerprint

Dive into the research topics of 'PROGRESS in Blood Pressure Control for the Prevention of Secondary Stroke'. Together they form a unique fingerprint.

Cite this